Blood -- Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3

Blood, Vol. 112, Issue 13, 5095-5102, December 15, 2008

Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
Blood Nelson et al. 112: 5095

Supplemental materials for: Nelson et al

Files in this Data Supplement:

Table S1. Relative inhibition of STAT3 phosphorylation at doses of Jak kinase inhibitors that cause equal inhibition of viability of INA6 multiple myeloma cells (PDF, )
Figure S1 (JPG, 24.6 KB) -
U266 cells were cultured in the presence or absence of BMSC for 6 hours with the indicated concentrations of nifuroxazide, and then examined by Western analysis with antibodies for (A) MAP kinase and phosphorylated MAP kinase, or (B) Akt and phosphorylated Akt.